Tirane 06. 06. 2010 (Rivleresimi apo rishikimi pas një viti) Titulli: astma bronkiale



Yüklə 0,89 Mb.
səhifə15/15
tarix16.03.2017
ölçüsü0,89 Mb.
#11648
1   ...   7   8   9   10   11   12   13   14   15

  • Stick SM, Arnott J, Turner DJ, Young S, Landau U, Lesouef PN. Bronchial responsiveness and lung function in recurrently wheezy infants. Am Rev RespirDis 1991 ;144:1012-5.

  • Sly PO, Cahill P, Willet K, Burton P. Accuracy of mini peak flow meters in indicating changes in lung function in children with asthma. BMJ 1994;308:572-4.

  • Eggleston PA. Exercise-induced asthma. In: Tinkleman DG, Naspitz CK, eds. Childhood asthma: pathophysiology and treatment. New York: Marcel Dekker; 1992. p. 429-46.

  • Dow L. Asthma in older people. Clin Exp Allergy 1998;28 SuppI5:195-202, discussion 3-5.

  • Tracey M, Villar A, Dow L, Coggon D, Lampe FC, Holgate ST. The influence of increased bronchial re-sponsiveness, atopy, and serum IgE on decline in FEV1. A longitudinal study in the elderly. Am J Respir Crit Care Med 1995;151 :656-62.

  • Paggiaro PL, Dahle R, Bakran I, Frith L, Hollingworth K, Efthimiou J. Multicentre randomised placebo-controlled trial of inhaled fluticasone propionate in patients with chronic obstructive pulmonary disease. International capo Study Group [published erratum appears in Lancet 1998;351: 1968]. Lancet 1998;351 :773-80.

  • Tarlo SM, Boulet LP, Cartier A, Cockcroft D, Cote J, Hargreave FE, et al. Canadian Thoracic Society guidelines for occupational asthma. Can Respir J 1998;5:289-300.

  • Chan-Yeung M, Maclean l, Paggiaro Pl. Follow-up study of 232 patients with occupational asthma caused by western red cedar (Thuja plicata). J Allergy Clin Immuno/1987;79:792-6.

  • Harju T, Keistinen T, Tuuponen T, Kivela Sl. Seasonal variation in childhood asthma hospitalisations in Finland, 1972-1992. Eur J Pediatr 1997;156:436-9.

  • Mitakakis TZ, Tovey ER, Xuan W, Marks GB. Personal exposure to allergenic pollen and mould spores in inland New South Wales, Australia. Clin Exp Allergy 2000;30: 1733-9.

  • O’Hollaren MT, Yunginger JW, Offord KP, Somers MJ, O’Connell EJ, Ballard OJ, et al. Exposure to an aeroallergen as a possible precipitating factor in respiratory arrest in young patients with asthma. N Engl J Med 1991 ;324:359-63.

  • Boulet lP, Cartier A, Thomson NC, Roberts RS, Oolovich J, Hargreave FE. Asthma and increases in nonallergic bronchial responsiveness from seasonal pollen exposure. J Allergy Clin Immunol 1983;71 :399-406.

  • Corrao WM, Braman SS, Irwin RS. Chronic cough as the sole presenting manifestation of bronchial asthma. N Engl J Med 1979;300:633-7.

  • Gibson PG, Oolovich J, Oenburg J, Ramsdale EH, Hargreave FE. Chronic cough: eosinophilic bronchitis without asthma. Lancet 1989; 1 : 13468.

  • Irwin RS, Curley FJ, French Cl. Chronic cough. The spectrum and frequency of causes, key components of the diagnostic evaluation, and outcome of specific therapy. Am Rev Respir Dis 1990;141:640-7.

  • Mok Q, Piesowicz AT. Foreign body aspiration mimicking asthma. Intensive Care Med 1993;19:240-1.

  • Place R, Morrison A, Arce E. Vocal cord dysfunction. J Adolesc Health 2000;27:125-9.

  • Bousquet J, Chanez P, Lacoste JY, Barneon G, Ghavanian N, Enander I, et al. Eosinophilic inflammation in asthma. N Engl J Med 1990;323:1033-9.

  • Cockcroft OW, Swystun VA. Asthma control versus asthma severity. J Allergy Clin Immunol 1996;98:1016-8.

  • Strunk RC. Identification of the fatality-prone subject with asthma. J Allergy Clin Immuno/ 1989;83:477-85.

  • Jalaludin BB, Smith MA, Chey T, Orr NJ, Smith WT, Leeder SR. Risk factors for asthma deaths: a population-based, case-control study. Aust N Z J Public Health 1999;23:595-600.

  • Levy M, Bell L. General practice audit of asthma in childhood. BMJ (Clin Res Ed) 1984;289:1115-6.

  • van Schayck CP, van Der Heijden FM, van Den Boom G, Tirimanna PR, van Herwaarden CL. Underdiagnosis of asthma: is the doctor or the patient to blame? The DIMCA project. Thorax 2000;55:562-5.

  • Gellert AR, Gellert SL, Iliffe SR. Prevalence and management of asthma in a London inner city general practice. Br J Gen Pract 1990;40:197-201.

  • Horn CR, Cochrane GM. Management of asthma in general practice. Respir Med 1989;83:67-70.

  • Horn CR, Essex E, Hill P, Cochrane GM. Does urinary salbutamol reflect compliance with the aerosol regimen in patients with asthma? Respir Med 1989;83: 15-8.

  • Rand CS, Wise RA, Nides M, Simmons MS, Bleecker ER, Kusek JW, et al. Metered-dose inhaler adherence in a clinical trial. Am Rev Respir Dis 1992;146:1559-64.

  • Spector SL, Kinsman R, Mawhinney H, Siegel SC, Rachelefsky GS, Katz RM, et al. Compliance of patients with asthma with an experimental aerosolized medication: implications for controlled clinical trials. J Allergy Clin Immuno/1986;77:65-70.

  • Strachan DP. Defining unmet need: relationship between asthma symptoms, asthma related disability, and level of treatment in a nationwide interview survey. Asthma 2000;5:137-40.

  • Blainey D, Lomas D, Beale A, Partridge M. The cost of acute asthma-how much is preventable? Health Trends 1990;22:151-3.

  • British Thoracic Association. Death from asthma in two regions of England. BMJ (Clin Res Ed) 1982;285: 1251-5.

  • Bucknall CE, Slack R, Godley CC, Mackay TW, Wright SC. Scottish Confidential Inquiry into Asthma Deaths (SCIAD), 1994-6. Thorax 1999;54:978-84.

  • Burr ML, Davies BH, Hoare A, Jones A, Williamson IJ, Holgate SK, et al. A confidential inquiry into asthma deaths in Wales. Thorax 1999;54:985-9.

  • Grimshaw JM, Russell IT. Effect of clinical guidelines on medical practice: a systematic review of rigorous evaluations. Lancet 1993;342:1317-22.

  • Smeele IJ, Grol RP, van Schayck CP, van den Bosch WJ, van den Hoogen HJ, Muris JW. Can small group education and peer review improve care for patients with asthma/chronic obstructive pulmonary disease? Qual Health Care 1999;8:92.

  • Neville RG, Hoskins G, Smith B, Clark RA. Observations on the structure, process and clinical outcomes of asthma care in general practice. Br J Gen Pract 1996;46:583-7.

  • Pearson MH, Bucknall CEo Measuring clinical outcomes in asthma. London: Royal College of Physicians; 1999.

  • Neville RG. Effective asthma audit. The Practitioner 1995;239:203-5.

  • Coutts JA, Gibson NA, Paton JV. Measuring compli- ance with inhaled medication in asthma. Arch Dis Child 1992;67:332-3.

  • Ong LM, de Haes JC, Hoos AM, Lammes FB. Doctor-patient communication: a review of the litera- ture. Soc SciMed 1995;40:903-18.

  • Stewart MA. Effective physician-patient communica- tion and health outcomes: a review. CMAJ 1995;152:1423-33.

  • Korsch BM, Negrete VF. Doctor-patient communication. Sci Am 1972;227:66-74.

  • Partridge MR, Hill SR. Enhancing care for people with asthma: the role of communication, education, training and self-management. 1998 World Asthma Meeting Education and Delivery of Care Working Group. Eur Respir J 2000; 16:333-48.

  • Clark NM, Gong M, Schork MA, Kaciroti N, Evans D, Roloff D, et al. Long-term effects of asthma education for physicians on patient satisfaction and use of health services. Eur Respir J 2000;16:15

  • Cegala DJ, Marinelli T, Post D. The effects of patient communication skills training on compliance. Arch Fam Med2000;9:57-64.

  • Jenkinson D, Davison J, Jones S, Hawtin P. Comparison of effects of a self management




    1. booklet and audiocassette for patients with asthma. BMJ 1988;297:267-70.

    2. Gibson PG, Coughlan J, Wilson AJ, Hensley MJ, Abramson M, Bauman A, et al. Limited (information only) patient education programs for adults with asthma. Cochrane Database Syst Rev 2000;(2):CDO01005.

    3. Hilton S, Sibbald B, Anderson HR, Freeling P. Controlled evaluation of the effects of patient educa-tion on asthma morbidity in general practice. Lancet 1986;1:26-9.

    4. Muhlhauser I, Richter B, Kraut D, Weske G, Worth H, Berger M. Evaluation of a structured treatment and teaching programme on asthma. J Intern Med 1991 ;230:157-64.

    5. Taggart VS, Zuckerman AE, Sly RM, Steinmueller C, Newman G, O’Brien RW, et al. You Can Control Asthma: evaluation of an asthma education program for hospitalized inner-city children. Patient Educ Couns 1991 ;17:35-47.

    6. Ringsberg KC, Wiklund I, Wilhelmsen L. Education of adult patients at an “asthma school”: effects on quality of life, knowledge and need for nursing. Eur Respir J 1990;3:33-7.

    7. Windsor RA, Bailey WC, Richards JM Jr, Manzella B, Soong SJ, Brooks M. Evaluation of the efficacy and cost effectiveness of health education methods to increase medication adherence among adults with asthma. Am J Public Health 1990;80:1519-21.

    8. Meade CD, McKinney WP, Barnas GP. Educating patients with limited literacy skills: the effectiveness of printed and videotaped materials about colon cancer. Am J Public Health 1994;84:119-21.

    9. Houts PS, Bachrach R, Witmer JT, Tringali CA, Bucher JA, Localio RA. Using pictographs to enhance recall of spoken medical instructions. Patient Educ Couns 1998;35:83-8.

    10. Gibson PG, Coughlan J, Wilson AJ, Abramson M, Bauman A, Hensley MJ, et al. Self-management ed- ucation and regular practitioner review for adults with asthma. Cochrane Database Syst Rev 2000;(2):CDO01117.

    11. Fishwick D, D’Souza W, Beasley R. The asthma self-management plan system of care: what does it mean, how is it done, does it work, what models are available, what do patients want and who needs it? Patient Educ Couns 1997;32:S21-33.

    12. Macdonald JB, Seaton A, Williams DA. Asthma deaths in Cardiff 1963-74: 90 deaths outside hospital. BMJ1976;1:1493-5.

    13. Rea HH, Sears MR, Beaglehole R, Fenwick J, Jackson RT, Gillies AJ, et al. Lessons from the National Asthma Mortality Study: circumstances surrounding death. N Z Med J 1987;100:10-3.

    14. Haahtela T, Jarvinen M, Kava T, Kiviranta K, Koskinen S, Lehtonen K, et al. Comparison of a beta 2-agonist, terbutaline, with an inhaled corticosteroid, budesonide, in newly detected asthma. N Engl J Med 1991 ;325:388-92.

    15. van Essen-Zandvliet EE, Hughes MD, Waalkens HJ, Duiverman EJ, Pocock SJ, Kerrebijn KF. Effects of 22 months of treatment with inhaled corticosteroids and/or beta-2-agonists on lung function, airway responsiveness, and symptoms in children with asthma. The Dutch Chronic Non- specific Lung Disease Study Group. Am Rev RespirDis 1992;146:547-54.

    16. Kerrebijn KF, van Essen-landv/iet EE, Neijens HJ. Effect of long-term treatment with inhaled corticosteroids and beta-agonists on the bronchial responsiveness in children with asthma. J Allergy Clin Immunol 1987;79:653-9.

    17. Platts-Mills TA, Tovey ER, Mitchell EB, Moszoro H, Nock P, Wilkins SR. Reduction of bronchial hyperreactivity during prolonged allergen avoidance. Lancet 1982;2:675-8.

    18. Chan-Yeung M, Leriche J, Maclean L, Lam S. Comparison of cellular and protein changes in bronchial lavage fluid of symptomatic and asymptomatic patients with red cedar asthma on follow-up examination. Clin Allergy 1988;18:359-65.

    19. Gibson PG, Wong BJ, Hepperle MJ, Kline PA, Girgis-Gabardo A, Guyatt G, et al. A research method to induce and examine a mild exacerbation of asthma by withdrawal of inhaled corticosteroid. Clin Exp Allergy 1992;22:525-32.

    20. Gupta D, Aggarwal AN, Subalaxmi MV, Jindal SK. Assessing severity of asthma: spirometric correlates with visual analogue scale (VAS). Indian J Chest Ois Allied Sci 2000;42:95-100.

    21. Sears MR. Increasing asthma mortality-fact or artifact? J Allergy Clin Immuno/1988;82:957-60.

    22. Lebowitz MD. The use of peak expiratory flow rate measurements in respiratory disease. Pediatr Pulmonol 1991 ;11 :166-74.

    23. National Heart, Lung, and Blood Institute. Statement on Technical Standards for Peak Flow Meters. Bethesda, MD: US Department of Health and Human Services; 1991. NIH Pub. No. 92-2133.

    24. Standardization of spirometry-1987 update. Statement of the American Thoracic Society. Am RevRespirOis 1987;136:1285-98.

    25. Reijonen TM, Korppi M. One-year follow-up of young children hospitalized for wheezing: the influence of early anti-inflammatory therapy and risk factors for subsequent wheezing and asthma. Pediatr Pulmonol 1998;26:113-9.

    26. Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC. Lung volumes and

    27. forced ventilatory flows. Report of Working Party for Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J 1993; 16:Suppl:5-40S.

    28. Quanjer PH, Lebowitz MD, Gregg I, Miller MR, Pedersen OF. Peak expiratory flow: conclusions and recommendations of a Working Party of the European Respiratory Society. Eur Respir J 1997;24 16 Suppl:2-8S.

    29. Ryan G, Latimer KM, Dolovich J, Hargreave FE. Bronchial responsiveness to histamine: relationship to diurnal variation of peak flow rate, improvement after bronchodilator, and airway calibre. Thorax 1982;37:423-9.

    30. Godfrey S, Kamburoff PL, Nairn JR. Spirometry, lung volumes and airway resistance in normal children aged 5 to 18 years. Br J Dis Chest 1970;64: 15-24.

    31. Gregg I, Nunn AJ. Peak expiratory flow in normal subjects. Br Med J 1973;3:282-4.

    32. Quackenboss JJ, Lebowitz MD, Krzyzanowski M. The normal range of diurnal changes in peak expiratory flow rates. Relationship to symptoms and respiratory disease. Am Rev Respir Dis 1991 ; 143:323-30.

    33. Reddel HK, Salome CM, Peat JK, Woolcock AJ. Which index of peak expiratory flow is most useful in the management of stable asthma? Am J Respir Crit Care Med 1995; 151 : 1320-5.

    34. National Asthma Education and Prevention Program. Guidelines for the diagnosis and management of asthma. Bethesda, MD: National Heart, Lung, and Blood Institute, National Institutes

    35. of Health; 1997. Available from http:// www.nhlbi.nih.gov.

    36. Asher I, Boner A, Chuchalin A, Custovic A, Dagli E, Haus M, et al. Prevention of allergy and asthma: interim report. Allergy 2000;55:1069-88.

    37. Jones CA, Holloway JA, Warner JO. Does atopic disease start in foetal life? Allergy 2000;55:2-10.

    38. Bousquet J, Yssel H, Vignola AM. Is allergic asthma associated with delayed fetal maturation or the persistence of conserved fetal genes? Allergy 2000;55:1194-7.

    39. Warner JO, Warner JA, Pohunek P, Rao R, Marguet C, Clough JB, et al. Markers of allergy & in- iflammation. Pediatr Allergy Immunol 1998;9:537.

    40. Jarrett EE, Miller HR. Production and activities of IgE in helminth infection. Prog Allergy 1982;31 :178-233.

    41. Jenmalm MC, Bjorksten B. Cord blood levels of immunoglobulin G subclass antibodies to food and inhalant allergens in relation to maternal atopy and the development of atopic disease during the first 8 years of life. Clin Exp Allergy 2000;30:34-40.

    42. Glovsky MM, Ghekiere L, Rejzek E. Effect of maternal immunotherapy on immediate skin test reactivity, specific rye IlgG and IgE antibody, and totallgE of the children. Ann Allergy 1991 ;67:21-4.

    43. Kramer MS. Maternal antigen avoidance during pregnancy for preventing atopic disease in infants of women at high risk. Cochrane Database Syst Rev 2000;2.

    44. Hide OW, Matthews S, Tariq S, Arshad SH. Allergen avoidance in infancy and allergy at 4 years of age. Allergy 1996;51 :89-93.

    45. Zeiger RS. Secondary prevention of allergic disease: an adjunct to primary prevention. Pediatr Allergy Immunol 1995;6:127-38.

    46. Isolauri E, Sutas Y, Salo MK, Isosomppi R, Kaila M. Elimination diet in cow’s milk allergy: risk for impaired growth in young children. J Pediatr 1998;132:1004-9.

    47. Kramer MS. Maternal antigen avoidance during lactation for preventing atopic disease in infants of women at high risk. Cochrane Database Syst Rev 2000;2.

    48. Sporik R, Holgate ST, Platts-Mills TA, Cogswell JJ. Exposure to house-dust mite allergen (Der p I) and the development of asthma in childhood. A prospective study. N Engl J Med 1990;323:502-7.

    49. Lau S, Illi S, Sommerfeld C, Niggemann B, Bergmann R, von Mutius E, et al. Early exposure to house-dust mite and cat allergens and development of childhood asthma: a cohort study. Multicentre Allergy Study Group. Lancet 2000;356:1392-7.

    50. Chan-Yeung M, McClean PA, Sandell PR, Slutsky AS, Zamel N. Sensitization to cat without direct exposure to cats. Clin Exp Allergy 1999;29:762-5.

    51. Ichikawa K, Iwasaki E, Baba M, Chapman MD. High prevalence of sensitization to cat allergen among Japanese children with asthma, living without cats. Clin Exp Allergy 1999;29:754-61.

    52. Hesselmar B, Aberg N, Aberg B, Eriksson B, Bjorksten B. Does early exposure to cat or dog protect against later allergy development? Clin Exp Allergy 1999;29:611-7.

    53. Platts-Mills TA, Vaughan JW, Blumenthal K, Pollart Squillace S, Sporik RB. Serum IgG and IgG4 antibodies to Fel d 1 among children exposed to 20 microg Fel d 1 at home: relevance of a nonallergic modified Th2 response. Int Arch Allergy Immunol 2001 ;124:126-9.

    54. Holt PG, Macaubas C. Development of long-term tolerance versus sensitisation to environmental allergens during the perinatal period. Curr Opin Immunol 1997;9:782-7.

    55. Warner JO. Worldwide variations in the prevalence of atopic symptoms: what does it all mean? Thorax 1999;54 Suppl 2:S46-51.

    56. Ball TM, Castro-Rodriguez JA, Griffith KA, Holberg CJ, Martinez FD, Wright AL. Siblings, day-care attendance, and the risk of asthma and wheezing during childhood. N Engl J Med 2000;343:538-43.

    57. Illi S, von Mutius E, Lau S, Bergmann R, Niggemann B, Sommerfeld C, et al. Early childhood infectious diseases and the development of asthma up to school age: a birth cohort study. BMJ 2001 ;322:390-5.

    58. Sigurs N, Bjarnason R, Sigurbergsson F, Kjellman B, Bjorksten B. Asthma and immunoglobulin E antibodies after respiratory syncytial virus bronchiolitis: a prospective cohort study with matched controls. Pediatrics 1995;95:500-5.

    59. Kopp-Hoolihan L. Prophylactic and therapeutic uses of probiotics: a review. JAm Diet Assoc 2001; 1 01 :229-38.

    60. Bjorksten B, Naaber P, Sepp E, Mikelsaar M. The intestinal microflora in allergic Estonian and Swedish 2-year-old children [published erratum appears in Glin ExpAllergy2000;30:1047]. Glin Exp Allergy 1999;29:342-6.

    61. Isolauri E, Sutas Y, Kankaanpaa P, Arvilommi H, Salminen S. Probiotics: effects on immunity. Am J Glin Nutr 2001 ;73:444S-50S.

    62. Strachan DP, Cook DG. Health effects of passive smoking. 6. Parental smoking and childhood asthma: longitudinal and case-control studies. Thorax 1998;53:204-12.

    63. Strachan DP, Cook DG. Health effects of passive smoking. 5. Parental smoking and allergic sensitisation in children. Thorax 1998;53:117-23.

    64. Kulig M, Luck W, Lau S, Niggemann B, Bergmann R, Klettke U, et al. Effect of pre- and postnatal tobacco smoke exposure on specific sensitization to food and inhalant allergens during the first 3 years of life. Multicenter Allergy Study Group, Germany. Allergy 1999;54:220-8.

    65. Martinez FD, Wright AL, Taussig LM, Holberg CJ, Halonen M, Morgan WJ. Asthma and wheezing in the first six years of life. The Group Health Medical Associates. N Engl J Med 1995;332:133-8.

    66. Dezateux C, Stocks J, Dundas I, Fletcher ME. Impaired airway function and wheezing in infancy: the influence of maternal smoking and a genetic predisposition to asthma. Am J Respir Grit Gare Med 1999;159:403-10.

    67. likura Y, Naspitz CK, Mikawa H, Talaricoficho S, Baba M, Sole D, et al. Prevention of asthma by ketotifen in infants with atopic dermatitis. Ann Allergy 1992;68:233-6.




  • Yüklə 0,89 Mb.

    Dostları ilə paylaş:
    1   ...   7   8   9   10   11   12   13   14   15




    Verilənlər bazası müəlliflik hüququ ilə müdafiə olunur ©azkurs.org 2024
    rəhbərliyinə müraciət

    gir | qeydiyyatdan keç
        Ana səhifə


    yükləyin